Cytosorbents Corp Sustainability Reports
CytoSorbents Corporation is a critical care-focused immunotherapy company that develops and commercializes blood purification technologies. Its flagship product, CytoSorb, is an extracorporeal cytokine adsorber designed to reduce deadly inflammation and organ failure.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300VI8WO8GK5QK793
FIGI: BBG001SL7YQ0
10 reports from 2015 to 2025
